Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BYH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,424
Award facts
- Contract value 100% obligated
- $10,423.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products, valued at $10,423.88 under a firm fixed-price contract awarded on December 22, 2025, with an ultimate completion date of December 23, 2025. This non-set-aside competitive award is performance-directed to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This contract facilitates product delivery to the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. The current delivery order for DUPIXENT, a specialty immunological medication, exemplifies the company's role as a key pharmaceutical vendor within the military medical supply chain and demonstrates the DLA's continued reliance on AmerisourceBergen's capabilities to support ongoing healthcare procurement requirements for federal personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F9BYH?
SPE2DR26F9BYH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F9BYH worth?
The government has obligated $10,424 on SPE2DR26F9BYH.
Is contract SPE2DR26F9BYH an order under another contract?
Yes. SPE2DR26F9BYH is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BYH competed?
The extent of competition for SPE2DR26F9BYH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award